Global Rheumatoid Arthritis (RA) Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4852854
- 103 Pages
- February 2022
- Medical Devices
The United States Rheumatoid Arthritis (RA) Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Rheumatoid Arthritis (RA) Drugs market, reaching US$ million by the year 2028. As for the Europe Rheumatoid Arthritis (RA) Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Rheumatoid Arthritis (RA) Drugs players cover AbbVie, Roche, Merck, and HEYL Chemisch-pharmazeutische Fabrik, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Rheumatoid Arthritis (RA) Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
NSAIDs
Analgesic Drugs
Corticosteroids
DMARDs
Biological Therapies
JAK-inhibitors
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AbbVie
Roche
Merck
HEYL Chemisch-pharmazeutische Fabrik
Johnson & Johnson
Amgen, Inc.
Pfizer
Bristol-Myers Squibb
UCB
GSK
Sanofi
Abbott Laboratories
Teva Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rheumatoid Arthritis (RA) Drugs Market Size 2017-2028
2.1.2 Rheumatoid Arthritis (RA) Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Rheumatoid Arthritis (RA) Drugs Segment by Type
2.2.1 NSAIDs
2.2.2 Analgesic Drugs
2.2.3 Corticosteroids
2.2.4 DMARDs
2.2.5 Biological Therapies
2.2.6 JAK-inhibitors
2.3 Rheumatoid Arthritis (RA) Drugs Market Size by Type
2.3.1 Rheumatoid Arthritis (RA) Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Type (2017-2022)
2.4 Rheumatoid Arthritis (RA) Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Rheumatoid Arthritis (RA) Drugs Market Size by Application
2.5.1 Rheumatoid Arthritis (RA) Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Application (2017-2022)
3 Rheumatoid Arthritis (RA) Drugs Market Size by Player
3.1 Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Players
3.1.1 Global Rheumatoid Arthritis (RA) Drugs Revenue by Players (2020-2022)
3.1.2 Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Rheumatoid Arthritis (RA) Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Rheumatoid Arthritis (RA) Drugs by Regions
4.1 Rheumatoid Arthritis (RA) Drugs Market Size by Regions (2017-2022)
4.2 Americas Rheumatoid Arthritis (RA) Drugs Market Size Growth (2017-2022)
4.3 APAC Rheumatoid Arthritis (RA) Drugs Market Size Growth (2017-2022)
4.4 Europe Rheumatoid Arthritis (RA) Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Rheumatoid Arthritis (RA) Drugs Market Size by Country (2017-2022)
5.2 Americas Rheumatoid Arthritis (RA) Drugs Market Size by Type (2017-2022)
5.3 Americas Rheumatoid Arthritis (RA) Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rheumatoid Arthritis (RA) Drugs Market Size by Region (2017-2022)
6.2 APAC Rheumatoid Arthritis (RA) Drugs Market Size by Type (2017-2022)
6.3 APAC Rheumatoid Arthritis (RA) Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Rheumatoid Arthritis (RA) Drugs by Country (2017-2022)
7.2 Europe Rheumatoid Arthritis (RA) Drugs Market Size by Type (2017-2022)
7.3 Europe Rheumatoid Arthritis (RA) Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rheumatoid Arthritis (RA) Drugs by Region (2017-2022)
8.2 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Rheumatoid Arthritis (RA) Drugs Market Forecast
10.1 Global Rheumatoid Arthritis (RA) Drugs Forecast by Regions (2023-2028)
10.1.1 Global Rheumatoid Arthritis (RA) Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Rheumatoid Arthritis (RA) Drugs Forecast
10.1.3 APAC Rheumatoid Arthritis (RA) Drugs Forecast
10.1.4 Europe Rheumatoid Arthritis (RA) Drugs Forecast
10.1.5 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Forecast
10.2 Americas Rheumatoid Arthritis (RA) Drugs Forecast by Country (2023-2028)
10.2.1 United States Rheumatoid Arthritis (RA) Drugs Market Forecast
10.2.2 Canada Rheumatoid Arthritis (RA) Drugs Market Forecast
10.2.3 Mexico Rheumatoid Arthritis (RA) Drugs Market Forecast
10.2.4 Brazil Rheumatoid Arthritis (RA) Drugs Market Forecast
10.3 APAC Rheumatoid Arthritis (RA) Drugs Forecast by Region (2023-2028)
10.3.1 China Rheumatoid Arthritis (RA) Drugs Market Forecast
10.3.2 Japan Rheumatoid Arthritis (RA) Drugs Market Forecast
10.3.3 Korea Rheumatoid Arthritis (RA) Drugs Market Forecast
10.3.4 Southeast Asia Rheumatoid Arthritis (RA) Drugs Market Forecast
10.3.5 India Rheumatoid Arthritis (RA) Drugs Market Forecast
10.3.6 Australia Rheumatoid Arthritis (RA) Drugs Market Forecast
10.4 Europe Rheumatoid Arthritis (RA) Drugs Forecast by Country (2023-2028)
10.4.1 Germany Rheumatoid Arthritis (RA) Drugs Market Forecast
10.4.2 France Rheumatoid Arthritis (RA) Drugs Market Forecast
10.4.3 UK Rheumatoid Arthritis (RA) Drugs Market Forecast
10.4.4 Italy Rheumatoid Arthritis (RA) Drugs Market Forecast
10.4.5 Russia Rheumatoid Arthritis (RA) Drugs Market Forecast
10.5 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Rheumatoid Arthritis (RA) Drugs Market Forecast
10.5.2 South Africa Rheumatoid Arthritis (RA) Drugs Market Forecast
10.5.3 Israel Rheumatoid Arthritis (RA) Drugs Market Forecast
10.5.4 Turkey Rheumatoid Arthritis (RA) Drugs Market Forecast
10.5.5 GCC Countries Rheumatoid Arthritis (RA) Drugs Market Forecast
10.6 Global Rheumatoid Arthritis (RA) Drugs Forecast by Type (2023-2028)
10.7 Global Rheumatoid Arthritis (RA) Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Rheumatoid Arthritis (RA) Drugs Product Offered
11.1.3 AbbVie Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Rheumatoid Arthritis (RA) Drugs Product Offered
11.2.3 Roche Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Rheumatoid Arthritis (RA) Drugs Product Offered
11.3.3 Merck Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Merck Main Business Overview
11.3.5 Merck Latest Developments
11.4 HEYL Chemisch-pharmazeutische Fabrik
11.4.1 HEYL Chemisch-pharmazeutische Fabrik Company Information
11.4.2 HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Product Offered
11.4.3 HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 HEYL Chemisch-pharmazeutische Fabrik Main Business Overview
11.4.5 HEYL Chemisch-pharmazeutische Fabrik Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Product Offered
11.5.3 Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Amgen, Inc.
11.6.1 Amgen, Inc. Company Information
11.6.2 Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Product Offered
11.6.3 Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Amgen, Inc. Main Business Overview
11.6.5 Amgen, Inc. Latest Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer Rheumatoid Arthritis (RA) Drugs Product Offered
11.7.3 Pfizer Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Pfizer Main Business Overview
11.7.5 Pfizer Latest Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Information
11.8.2 Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Product Offered
11.8.3 Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Bristol-Myers Squibb Main Business Overview
11.8.5 Bristol-Myers Squibb Latest Developments
11.9 UCB
11.9.1 UCB Company Information
11.9.2 UCB Rheumatoid Arthritis (RA) Drugs Product Offered
11.9.3 UCB Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 UCB Main Business Overview
11.9.5 UCB Latest Developments
11.10 GSK
11.10.1 GSK Company Information
11.10.2 GSK Rheumatoid Arthritis (RA) Drugs Product Offered
11.10.3 GSK Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 GSK Main Business Overview
11.10.5 GSK Latest Developments
11.11 Sanofi
11.11.1 Sanofi Company Information
11.11.2 Sanofi Rheumatoid Arthritis (RA) Drugs Product Offered
11.11.3 Sanofi Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Sanofi Main Business Overview
11.11.5 Sanofi Latest Developments
11.12 Abbott Laboratories
11.12.1 Abbott Laboratories Company Information
11.12.2 Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Product Offered
11.12.3 Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Abbott Laboratories Main Business Overview
11.12.5 Abbott Laboratories Latest Developments
11.13 Teva Pharmaceutical
11.13.1 Teva Pharmaceutical Company Information
11.13.2 Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Product Offered
11.13.3 Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Teva Pharmaceutical Main Business Overview
11.13.5 Teva Pharmaceutical Latest Developments
12 Research Findings and Conclusion
Table 1. Rheumatoid Arthritis (RA) Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of NSAIDs
Table 3. Major Players of Analgesic Drugs
Table 4. Major Players of Corticosteroids
Table 5. Major Players of DMARDs
Table 6. Major Players of Biological Therapies
Table 7. Major Players of JAK-inhibitors
Table 8. Rheumatoid Arthritis (RA) Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Rheumatoid Arthritis (RA) Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 10. Global Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Type (2017-2022)
Table 11. Rheumatoid Arthritis (RA) Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 12. Global Rheumatoid Arthritis (RA) Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 13. Global Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Application (2017-2022)
Table 14. Global Rheumatoid Arthritis (RA) Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 15. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Player (2020-2022)
Table 16. Rheumatoid Arthritis (RA) Drugs Key Players Head office and Products Offered
Table 17. Rheumatoid Arthritis (RA) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Rheumatoid Arthritis (RA) Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 21. Global Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Regions (2017-2022)
Table 22. Americas Rheumatoid Arthritis (RA) Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 23. Americas Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Country (2017-2022)
Table 24. Americas Rheumatoid Arthritis (RA) Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 25. Americas Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Type (2017-2022)
Table 26. Americas Rheumatoid Arthritis (RA) Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 27. Americas Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Application (2017-2022)
Table 28. APAC Rheumatoid Arthritis (RA) Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 29. APAC Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Region (2017-2022)
Table 30. APAC Rheumatoid Arthritis (RA) Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 31. APAC Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Type (2017-2022)
Table 32. APAC Rheumatoid Arthritis (RA) Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 33. APAC Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Application (2017-2022)
Table 34. Europe Rheumatoid Arthritis (RA) Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 35. Europe Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Country (2017-2022)
Table 36. Europe Rheumatoid Arthritis (RA) Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 37. Europe Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Type (2017-2022)
Table 38. Europe Rheumatoid Arthritis (RA) Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 39. Europe Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Application (2017-2022)
Table 40. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Region (2017-2022)
Table 42. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Type (2017-2022)
Table 44. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Application (2017-2022)
Table 46. Key Market Drivers & Growth Opportunities of Rheumatoid Arthritis (RA) Drugs
Table 47. Key Market Challenges & Risks of Rheumatoid Arthritis (RA) Drugs
Table 48. Key Industry Trends of Rheumatoid Arthritis (RA) Drugs
Table 49. Global Rheumatoid Arthritis (RA) Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 50. Global Rheumatoid Arthritis (RA) Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 51. Global Rheumatoid Arthritis (RA) Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 52. Global Rheumatoid Arthritis (RA) Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 53. Global Rheumatoid Arthritis (RA) Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 54. Global Rheumatoid Arthritis (RA) Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 55. AbbVie Details, Company Type, Rheumatoid Arthritis (RA) Drugs Area Served and Its Competitors
Table 56. AbbVie Rheumatoid Arthritis (RA) Drugs Product Offered
Table 57. AbbVie Rheumatoid Arthritis (RA) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 58. AbbVie Main Business
Table 59. AbbVie Latest Developments
Table 60. Roche Details, Company Type, Rheumatoid Arthritis (RA) Drugs Area Served and Its Competitors
Table 61. Roche Rheumatoid Arthritis (RA) Drugs Product Offered
Table 62. Roche Main Business
Table 63. Roche Rheumatoid Arthritis (RA) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 64. Roche Latest Developments
Table 65. Merck Details, Company Type, Rheumatoid Arthritis (RA) Drugs Area Served and Its Competitors
Table 66. Merck Rheumatoid Arthritis (RA) Drugs Product Offered
Table 67. Merck Main Business
Table 68. Merck Rheumatoid Arthritis (RA) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 69. Merck Latest Developments
Table 70. HEYL Chemisch-pharmazeutische Fabrik Details, Company Type, Rheumatoid Arthritis (RA) Drugs Area Served and Its Competitors
Table 71. HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Product Offered
Table 72. HEYL Chemisch-pharmazeutische Fabrik Main Business
Table 73. HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 74. HEYL Chemisch-pharmazeutische Fabrik Latest Developments
Table 75. Johnson & Johnson Details, Company Type, Rheumatoid Arthritis (RA) Drugs Area Served and Its Competitors
Table 76. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Product Offered
Table 77. Johnson & Johnson Main Business
Table 78. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 79. Johnson & Johnson Latest Developments
Table 80. Amgen, Inc. Details, Company Type, Rheumatoid Arthritis (RA) Drugs Area Served and Its Competitors
Table 81. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Product Offered
Table 82. Amgen, Inc. Main Business
Table 83. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 84. Amgen, Inc. Latest Developments
Table 85. Pfizer Details, Company Type, Rheumatoid Arthritis (RA) Drugs Area Served and Its Competitors
Table 86. Pfizer Rheumatoid Arthritis (RA) Drugs Product Offered
Table 87. Pfizer Main Business
Table 88. Pfizer Rheumatoid Arthritis (RA) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 89. Pfizer Latest Developments
Table 90. Bristol-Myers Squibb Details, Company Type, Rheumatoid Arthritis (RA) Drugs Area Served and Its Competitors
Table 91. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Product Offered
Table 92. Bristol-Myers Squibb Main Business
Table 93. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 94. Bristol-Myers Squibb Latest Developments
Table 95. UCB Details, Company Type, Rheumatoid Arthritis (RA) Drugs Area Served and Its Competitors
Table 96. UCB Rheumatoid Arthritis (RA) Drugs Product Offered
Table 97. UCB Main Business
Table 98. UCB Rheumatoid Arthritis (RA) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 99. UCB Latest Developments
Table 100. GSK Details, Company Type, Rheumatoid Arthritis (RA) Drugs Area Served and Its Competitors
Table 101. GSK Rheumatoid Arthritis (RA) Drugs Product Offered
Table 102. GSK Main Business
Table 103. GSK Rheumatoid Arthritis (RA) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. GSK Latest Developments
Table 105. Sanofi Details, Company Type, Rheumatoid Arthritis (RA) Drugs Area Served and Its Competitors
Table 106. Sanofi Rheumatoid Arthritis (RA) Drugs Product Offered
Table 107. Sanofi Rheumatoid Arthritis (RA) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 108. Sanofi Main Business
Table 109. Sanofi Latest Developments
Table 110. Abbott Laboratories Details, Company Type, Rheumatoid Arthritis (RA) Drugs Area Served and Its Competitors
Table 111. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Product Offered
Table 112. Abbott Laboratories Main Business
Table 113. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 114. Abbott Laboratories Latest Developments
Table 115. Teva Pharmaceutical Details, Company Type, Rheumatoid Arthritis (RA) Drugs Area Served and Its Competitors
Table 116. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Product Offered
Table 117. Teva Pharmaceutical Main Business
Table 118. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 119. Teva Pharmaceutical Latest Developments
List of Figures
Figure 1. Rheumatoid Arthritis (RA) Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Type in 2021
Figure 7. Rheumatoid Arthritis (RA) Drugs in Hospitals
Figure 8. Global Rheumatoid Arthritis (RA) Drugs Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Rheumatoid Arthritis (RA) Drugs in Clinics
Figure 10. Global Rheumatoid Arthritis (RA) Drugs Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Rheumatoid Arthritis (RA) Drugs in Others
Figure 12. Global Rheumatoid Arthritis (RA) Drugs Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Application in 2021
Figure 14. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Player in 2021
Figure 15. Global Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Rheumatoid Arthritis (RA) Drugs Market Size 2017-2022 ($ Millions)
Figure 17. APAC Rheumatoid Arthritis (RA) Drugs Market Size 2017-2022 ($ Millions)
Figure 18. Europe Rheumatoid Arthritis (RA) Drugs Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size 2017-2022 ($ Millions)
Figure 20. Americas Rheumatoid Arthritis (RA) Drugs Value Market Share by Country in 2021
Figure 21. Americas Rheumatoid Arthritis (RA) Drugs Consumption Market Share by Type in 2021
Figure 22. Americas Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Application in 2021
Figure 23. United States Rheumatoid Arthritis (RA) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Rheumatoid Arthritis (RA) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Rheumatoid Arthritis (RA) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Rheumatoid Arthritis (RA) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Region in 2021
Figure 28. APAC Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Application in 2021
Figure 29. China Rheumatoid Arthritis (RA) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Rheumatoid Arthritis (RA) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Rheumatoid Arthritis (RA) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Rheumatoid Arthritis (RA) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Rheumatoid Arthritis (RA) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Rheumatoid Arthritis (RA) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Country in 2021
Figure 36. Europe Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Type in 2021
Figure 37. Europe Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Application in 2021
Figure 38. Germany Rheumatoid Arthritis (RA) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Rheumatoid Arthritis (RA) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Rheumatoid Arthritis (RA) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Rheumatoid Arthritis (RA) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Rheumatoid Arthritis (RA) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Application in 2021
Figure 46. Egypt Rheumatoid Arthritis (RA) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Rheumatoid Arthritis (RA) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Rheumatoid Arthritis (RA) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Rheumatoid Arthritis (RA) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Rheumatoid Arthritis (RA) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 52. APAC Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 53. Europe Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 55. United States Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Canada Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 59. China Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Japan Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 61. Korea Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 63. India Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 64. Australia Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 65. Germany Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 66. France Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 67. UK Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Italy Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 69. Russia Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 70. Spain Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 73. Israel Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Rheumatoid Arthritis (RA) Drugs Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
